Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type 1 diabetes

Details for Australian Patent Application No. 2009246134 (hide)

Owner The Royal Institution for the Advancement of Learning/McGill University The Children's Hospital of Philadelphia

Inventors Hakonarson, Hakon; Bradfield, Jonathan; Grant, Struan; Qu, Hui-Qi; Polychronakos, Constantin

Agent Pizzeys

Pub. Number AU-A-2009246134

PCT Pub. Number WO2009/140679

Priority 61/054,040 16.05.08 US

Filing date 18 May 2009

Wipo publication date 19 November 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

9 December 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type I diabetes

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140679 Priority application(s): WO2009/140679

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246137-Systems, devices and methods for accessing a bodily opening

2009246130-Combination therapy with PM00 104 and another antitumor agent